Published in
Elsevier, Urologic Oncology: Seminars and Original Investigations, 12(34), p. 530.e15-530.e21
DOI: 10.1016/j.urolonc.2016.07.005
Links
Tools
Phase 1/2 multiple ascending dose trial of the prostate-specific membrane antigen-targeted antibody drug conjugate MLN2704 in metastatic castration-resistant prostate cancer
Journal article published in 2016 by
Matthew I. Milowsky,
Matthew D. Galsky,
Michael J. Morris,
Daniel J. Crona 
,
Daniel J. George,
Robert Dreicer,
Kin Tse,
Jesika Petruck,
Iain J. Webb,
Neil H. Bander,
David M. Nanus,
Howard I. Scher
,
Daniel J. George,
Robert Dreicer,
Kin Tse,
Jesika Petruck,
Iain J. Webb,
Neil H. Bander,
David M. Nanus,
Howard I. Scher
This paper was not found in any repository, but could be made available legally by the author.
Full text: Unavailable
Published version:
archiving forbidden
Data provided by 